eticlopride has been researched along with dextroamphetamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garrett, BE; Holtzman, SG | 1 |
Hoffman, DC | 1 |
Puotz, JK; Rebec, GV; Rosa-Kenig, A | 1 |
LaHoste, GJ; Marshall, JF; Ruskin, DN | 1 |
Bardo, MT; Brown, RW; Kraemer, PJ; Mace, DD; Phillips, SB | 1 |
Broening, HW; Morford, LL; Vorhees, CV | 1 |
Izzo, E; Koob, GF; Sanna, PP | 1 |
Floresco, SB; St Onge, JR | 1 |
8 other study(ies) available for eticlopride and dextroamphetamine
Article | Year |
---|---|
D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Caffeine; Dextroamphetamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Sulpiride | 1994 |
The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.
Topics: Animals; Conditioning, Psychological; Dextroamphetamine; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reward; Salicylamides | 1994 |
The involvement of D1 and D2 dopamine receptors in amphetamine-induced changes in striatal unit activity in behaving rats.
Topics: Animals; Benzazepines; Corpus Striatum; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Evoked Potentials; Male; Motor Activity; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Sulpiride | 1993 |
Dopaminergic regulation of immediate early gene expression in the basal ganglia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Basal Ganglia; Cocaine; Dextroamphetamine; Dopamine; Dopamine Antagonists; Gene Expression Regulation; Genes, Immediate-Early; Male; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides | 1998 |
D-amphetamine facilitation of morris water task performance is blocked by eticlopride and correlated with increased dopamine synthesis in the prefrontal cortex.
Topics: Animals; Central Nervous System Stimulants; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Male; Maze Learning; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Salicylamides | 2000 |
Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Topics: Animals; Benzazepines; Body Temperature; Chromatography, High Pressure Liquid; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fever; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Serotonin | 2005 |
Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Corticotropin-Releasing Hormone; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Injections, Intraventricular; Male; Mice; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior; Time Factors | 2005 |
Dopaminergic modulation of risk-based decision making.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides | 2009 |